Characteristics | No | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
Hazard ratio (95% CI) | P | Hazard ratio (95% CI) | P | ||
Age | 77 | 1.042 (1.000—1.085) | 0.052 | 0.977 (0.915–1.043) | 0.480 |
Menopause | 77 | Â | 0.036 | Â | Â |
 No | 15 | Reference |  | Reference |  |
 Yes | 58 | 3.336 (0.775–14.360) | 0.106 | 2.256 (0.282–18.033) | 0.443 |
 Unknown | 4 | 0.000 (0.000–Inf) | 0.998 | 0.000 (0.000–Inf) | 0.999 |
BMI | 54 | 0.908 (0.757–1.089) | 0.298 |  |  |
Chemotherapy | 77 | Â | 0.029 | Â | Â |
 No | 15 | Reference |  | Reference |  |
 Yes | 62 | 0.356 (0.149–0.851) | 0.020 | 0.524 (0.183–1.497) | 0.228 |
Radiotherapy | 77 | Â | 0.002 | Â | Â |
 No | 42 | Reference |  | Reference |  |
 Yes | 35 | 0.217 (0.073–0.641) | 0.006 | 0.144 (0.044–0.464) | 0.001 |
Myometrial infiltration (> = 1/2) | 77 |  | 0.128 |  |  |
 No | 25 | Reference |  |  |  |
 Yes | 50 | 2.292 (0.765–6.870) | 0.139 |  |  |
 Unknown | 2 | 9.137 (0.989–84.410) | 0.051 |  |  |
Lymph node metastasis | 77 | Â | 0.023 | Â | Â |
 No | 15 | Reference |  | Reference |  |
 Yes | 58 | 6.157 (0.823–46.057) | 0.077 | 10.666 (1.303–87.304) | 0.027 |
 Unknown | 4 | 17.198 (1.535–192.721) | 0.021 | 16.373 (1.302–205.940) | 0.030 |
Pathological type | 77 |  |  < 0.001 |  |  |
 UEC | 29 | Reference |  | Reference |  |
 UCCC | 7 | 3.393 (0.563–20.450) | 0.182 | 5.367 (0.692–41.590) | 0.108 |
 USC | 37 | 7.694 (2.206–26.830) | 0.001 | 5.950 (1.613–21.951) | 0.007 |
 UMC | 4 | 0.000 (0.000–Inf) | 0.998 | 0.000 (0.000–Inf) | 0.998 |